Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

HealthRX vs Liberty

HealthRX
Graded #8

Higher grade

vs+25.099999999999994
Liberty
Graded #304

Lower grade

The verdict

HealthRX takes it — 86.1/100 to 61/100.

HealthRX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A LegitScript-certified (#50087439) physician-supervised program that runs a rare oral GLP tablet alongside the usual injectables — compounded semaglutide from ~$189/mo, tirzepatide/GLP+GIP up to ~$349, with a brand Ozempic pass-through if you need it.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueHealthRX +41
85
44
Dose & formulationHealthRX +13
90
77
Clinical oversightHealthRX +11
87
76
Labs & monitoringHealthRX +28
82
54
FulfillmentHealthRX +5
86
81
Contract termsHealthRX +65
85
20
HealthRX · left barLiberty · right bar

The numbers

MetricHealthRXLiberty
WeighScore86.1/10061/100
GradeBC
Scorecard rank#8#304
Semaglutide$189/mo$199/mo (compounded)
Tirzepatide$349/mo$299/mo (compounded)
CoverageNot publicly listedCoverage not published
Brand-name accessYesYes
Oral / sublingualYesInjection only
HealthRX

Graded #8 · B

Strengths

  • LegitScript-certified (#50087439) — a genuine, verifiable trust signal
  • Physician-supervised intake with licensed providers
  • Both molecules plus a rare oral GLP tablet option
  • Transparent flat monthly pricing, no insurance required

Where it loses points

  • Compounded semaglutide/tirzepatide is not FDA-approved
  • Some tiers are company-stated and the public site is thin
  • Brand Ozempic is a steep pass-through (~$1,299)
  • State count is not publicly listed
Liberty

Graded #304 · C

Strengths

  • Compounded GLP-1 sourced from FDA-registered 503B outsourcing facilities, a stricter standard than the 503A pharmacies many competitors use
  • Transparent flat pricing: compounded semaglutide $199/mo (about $171/mo on a 3-month supply) and tirzepatide $299/mo
  • Nationwide in all 50 states with free discreet shipping, 24/7 support, and FSA/HSA acceptance
  • Multi-vertical menu beyond weight loss (low-dose microdosing, NAD+, sermorelin, metformin) for patients who want bundled wellness care

Where it loses points

  • Does not name its specific compounding pharmacy partner, only that it is a 503B facility
  • Tirzepatide at $299/mo is mid-market rather than the cheapest option among compounded providers
  • Generic corporate branding (Liberty Health) with limited public detail on the operating entity
  • Compounded medication only — no brand-name or insurance-covered GLP-1 path

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard